| Aurelia Barbara Koziel-andrzejewska, | |
|
1625 Maple Ln, Ashland, WI 54806-3768 | |
| (715) 685-7500 | |
| (715) 682-2481 |
| Full Name | Aurelia Barbara Koziel-andrzejewska |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 1625 Maple Ln, Ashland, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578593869 | NPI | - | NPPES |
| 34429000 | Medicaid | WI | |
| 452449700 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 45604-020 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Aurelia Barbara Koziel-andrzejewska, 1625 Maple Ln, Ashland, WI 54806-3768 Ph: (715) 685-7500 | Aurelia Barbara Koziel-andrzejewska, 1625 Maple Ln, Ashland, WI 54806-3768 Ph: (715) 685-7500 |
News Archive
Colorectal cancer patients who followed healthy diets had a lower risk of death from colorectal cancer and all causes, even those who improved their diets after being diagnosed, according to a new American Cancer Society study.
On her laptop computer one recent afternoon, University at Buffalo researcher Charmion Cruickshank calls up a mass spectrometry readout showing the breakdown of chemicals in the urine of a child with autism.
Prenatal exposure to nicotine could manifest as attention deficit hyperactivity disorder in children born a generation later, according to a new study by Florida State University College of Medicine researchers.
Pre-eclampsia is a serious complication of pregnancy that currently affects 6-8% of all pregnancies in Australia. Griffith Health Institute researchers have recently found that multivitamin supplements, including those that contain selenium, can reduce the incidence of PE, especially for overweight mothers.
Ampio Pharmaceuticals, Inc. announced today that the FDA has accepted the Company's IND for Optina™ for the treatment of diabetic macular edema (DME). Ampio plans to commence enrollment in a clinical trial in the first quarter of 2013. The FDA granted Optina™ 505(b)(2) status in July, 2012. Drugs designated under this pathway can be approved on a single trial.
› Verified 7 days ago
John Florian Hussa, MD AODAC Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1615 Maple Ln, Ashland, WI 54806 Phone: 715-685-5500 Fax: 715-685-5102 | |
Dr. Stuart Hawley Sheets, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1635 Maple Ln, Ashland, WI 54806 Phone: 715-685-5400 Fax: 715-685-5102 |